Artificial intelligence (AI) software developer Icometrix said that its icobrain cva software for analyzing ischemic stroke has received U.S. Food and Drug Administration (FDA) clearance and the CE Mark.
Designed to analyze tissue perfusion state on CT perfusion scans in ischemic stroke patients, icobrain cva reports the volume of the core and perfusion lesion by quantifying reduced cerebral blood flow, volume, and transit time, according to the vendor. The cloud-based software delivers perfusion maps and a report that includes the correctness of the selected arterial input function and the quality of the output, Icometrix said.
